Abstract
e14554Background: Everolimus (EV) is an oral inhibitor of mammalian target of rapamicin (mTOR), recently approved in combination with exemestane (EX) for the treatment of hormonal positive metastat...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have